Skip to main content
Veterinary Medicines

PRILENAL 1 MG, TABLETS

Not authorised
  • Enalapril maleate

Product identification

Medicine name:
PRILENAL 1 MG, TABLETS
PRILENAL, 1mg, Tableta
Active substance:
  • Enalapril maleate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Enalapril maleate
    1.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QC09AA02
Authorisation status:
  • Surrendered
Authorised in:
  • Czechia
Package description:
  • Box containing 12 blisters of 7 tablets
  • Box containing 24 blisters of 7 tablets
  • Box containing 4 blisters of 7 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Ceva Sante Animale
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva Sante Animale
  • EUROPHARTECH
Responsible authority:
  • Institute For State Control Of Veterinary Biologicals And Medicaments
Authorisation number:
  • 96/041/05-C
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0152/001

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022

Labelling

This document does not exist in this language (English). You can find it in another language below.
Czech (PDF)
Published on: 25/10/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."